Fig. 4From: Cocktail treatment with EGFR-specific and CD133-specific chimeric antigen receptor-modified T cells in a patient with advanced cholangiocarcinomaThe levels of IL-6 and CRP during and after the infusion of CART-EGFR and CART133 cellsBack to article page